> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Newtyn Management's Funds Hold About 8% Of QuidelOrtho Without Seeking To Influence Control
- URL: https://www.bullished.co/newtyn-managements-funds-hold-about-8-of-quidelortho-without-seeking-to-influence-control-e0495058/
- Published: 2026-11-17T01:01:32.000Z
- Updated: 2026-11-17T01:01:32.000Z
- Description: The investment manager reported voting and disposal authority over 5,342,283 shares held by its funds.
- Author: Matteo Parrino
- Tags: SEC Filings, QDEL, Industry: Healthcare, Topic: Ownership & Activism

Newtyn Management, an investment manager, reported an [about 8% stake](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052316/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [QuidelOrtho](https://www.bullished.co/tag/qdel/), which makes diagnostic tests and the instruments used to run them. Monday's SEC passive ownership disclosure put the position at 5,342,283 shares and certified that the reporting persons were not holding the stock to change or influence company control.

## The Funds Behind The Stake

The holdings belonged to funds managed by Newtyn Management as of September 30, 2026\. The manager reported 7.8% ownership, rounded to about 8%, because its authority over those funds means their shares can be counted as its beneficial ownership.

Newtyn TE Partners, one of the managed funds and a reporting person alongside the manager, held [3,443,720 shares](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052316/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co), representing 5% of the class. Newtyn Partners, the other managed fund, held 1,898,563 shares.

Newtyn Management reported sole authority to vote and dispose of the full position. Newtyn TE Partners reported the same authority over its own holdings; neither reporting person listed shared authority.

The reporting persons retained their passive-investment certification. They certified that neither acquiring nor holding the shares had the purpose or effect of changing or influencing QuidelOrtho's control.

## A Stake In Diagnostic Testing

QuidelOrtho serves hospitals, laboratories, physician offices, urgent care clinics, pharmacies, blood banks and donor centers. Its products cover clinical chemistry, immunoassay and molecular testing, rapid point-of-care testing, and blood typing and screening for transfusions. Some tests are sold for home use.

The company sells through its own sales team and distributors, reaching customers in more than 140 countries and territories. Its revenue spans Labs, Transfusion Medicine, Point of Care and Molecular Diagnostics, as well as contract manufacturing and collaborations.

Newtyn's ownership calculation used approximately 68,575,427 outstanding common shares as of July 29, 2026\. QuidelOrtho supplied that denominator in its quarterly report filed August 7, 2026.

The reported stake combines the managed funds' holdings under Newtyn Management's voting and disposal authority, with the passive-control certification still in place.

Learn

- [13D Filing Requirements And Deadline, Shown With Real Filings →](https://www.bullished.co/learn/13d-filing-requirements/)  
A Schedule 13D is required when you own more than 5% of a public company's voting shares. See the deadline, contents and real filings from this week.
- [13D Vs 13G: What Each 5% Stake Filing Means And How To Read One →](https://www.bullished.co/learn/13d-vs-13g/)  
13D vs 13G: both report stakes above 5%, but 13G is the short passive form and 13D explains intent. See real BlackRock and Pictet filings read in plain English.

### Sources

- [SCHEDULE 13G/A — Newtyn Management, LLC re: QuidelOrtho Corporation (QDEL)](https://www.sec.gov/Archives/edgar/data/0001569241/000149315226052316/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR

### More on QuidelOrtho

- [QuidelOrtho Gets Lenders To Allow 5.50x Leverage Through 2028 While Cash Burn Continues](https://www.bullished.co/quidelortho-gets-lenders-to-allow-5-50x-leverage-through-2028-while-cash-burn-continues-c4ef8551/)
- [QuidelOrtho Launches Restructuring Targeting Over $80 Million In 2027 Savings, As CEO Weighs 'Every Option' On Debt](https://www.bullished.co/quidelortho-launches-restructuring-targeting-over-80-million-in-2027-savings-as-ceo-weighs-48deb372/)
- [QuidelOrtho Revenue Falls 12% To $619 Million, Trims Outlook And Starts Restructuring](https://www.bullished.co/quidelortho-revenue-falls-12-to-619-million-trims-outlook-and-starts-restructuring-b6232a59/)

[All QuidelOrtho (QDEL) coverage →](https://www.bullished.co/tag/qdel/)